Haemophilia A Clinical Trial: Safety and Pharmacokinetics of NNC ...
Clinical Trials Authorship and Review Clinical Trials content is provided directly by the U. S. National Institutes of Health via ClinicalTrials. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health. Any history of FVIII inhibitors Surgery planned to occur during the trial Platelet count less than 50,000 platelets/microlitre (assessed by laboratory) Congenital or acquired coagulation disorders other than haemophilia A Information obtained from... Clinical Trials at Novo Nordisk. Haemophilia A Body Mass Index (BMI) below 35 kg/m2 History of a minimum 150 exposure days (EDs) to FVIII products (prophylaxis/prevention/surgery/on-demand) Exclusion Criteria:. gov Identifier: NCT01205724. gov and is not reviewed separately by ClinicalTrialsFeeds. gov/show/NCT01205724. Health Authority: Germany: Federal Institute for Drugs and Medicinal Devices (BfarM). Link to the current ClinicalTrials. gov on September 19, 2010. gov record. http://clinicaltrials.
A Guide to Understanding Clinical Trials brought to you by www.ClinicalConnection.com To find clinical trials listings please visit http
Start of in-Patient Clinical Trials With NT-KO-003, the First Neuroprotective ...
19.07.11
, "the promising results of
NT-KO-003 in animals convinced us to start clinical trials in MS
patients. We managed to involve doctors and patients' associations
in the design of the trial protocol and we believe the study meets
the current needs of MS patients"
"At present, the main concern of MS patients is to maintain a
good quality of life. They need to stop the progression of the
disease, or at least to slow down, and if possible to recover from
the serious side-effects. Since MS is a chronic disease that
affects young people who are working and have families, new
treatments should be easy to manage and should have no side
effects, so as not to interfere with patients lives. NT-KO-003
holds great great promise because of its safety and ease-of-use,
which are very good, and unlike current drugs it does not alter
patients' quality of life, and also because it's mechanism of
action Is new and complementary to existing treatments" ,
says Dr. Villoslada. "Furthrmore, all the neurologists
participating in this study are really motivated because this
treatment has arisen from basic research done by colleagues from
our country and may be beneficial to our patients. This is an
example of real innovation"
Mar 16, 2007 by LittleAnnie | Posted in Other - General Health Care
I'm thinking of volunteering for clinical trials - I hear it is well paid and helps progress medical research which in turn helps others! On the other hand, there could be side effects etc..... What are your opinions on this?
My husband has participated in a few clinical trials in the past, and yes, participants are VERY well compensated for their time and travel, but you must consider the fact that you will essentially be a guinea pig and there could be many undesirable and
camd42 | Mar 16, 2007
It is very well paid. I think in light of the horrendous side effects that those poor men suffered last year (UK) I would have to think twice, then think again. I know it's vital to research, but I'm not sure I'm brave enough to risk my health. Big question
sandy s | Mar 16, 2007
clinical trials?
Jul 04, 2007 by medotech | Posted in Cancer
Hi everyone,
I am thinking of signing up for a clinical trial for the treatment for hypertention.Apart from helping fine a cure,i am also doing to get paid as i am a college student and really need that cash for school next semester or i will have